Piard J et al. (2020), The GRIA3 c.2477G > A Variant Causes an Exagger...

XB-ART-56956

Mov Disord 2020 Jul 01;357:1224-1232. doi: 10.1002/mds.28058.

Show Gene links Show Anatomy links

The GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus.

Piard J , Béreau M , XiangWei W , Wirth T , Amsallem D , Buisson L , Richard P , Liu N , Xu Y , Myers SJ , Traynelis SF , Chelly J , Anheim M , Raynaud M , Maldergem LV , Yuan H .

???displayArticle.abstract???
BACKGROUND: Hemizygous mutations in GRIA3 encoding the GluA3 subunit of the amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor are known to be associated with neurodevelopmental disorders, including intellectual disability, hypotonia, an autism spectrum disorder, sleep disturbances, and epilepsy in males. OBJECTIVE: To describe a new and consistent phenotype in 4 affected male patients associated with an undescribed deleterious variant in GRIA3. METHODS: We evaluated a large French family in which segregate a singular phenotype according to an apparent X-linked mode of inheritance. Molecular analyses using next generation sequencing and in vitro functional studies using 2-electrode voltage clamp recordings on Xenopus laevis oocytes and a β-lactamase reporter assay in transfected human embryonic kidney (HEK293) cells were performed. RESULTS: In addition to mild intellectual disability and dysarthria, affected patients presented a tightly consistent early-onset movement disorder combining an exaggerated startle reflex with generalized chorea and multifocal myoclonus. The unreported GRIA3 missense variant c.2477G > A; p.(Gly826Asp) affecting the fourth transmembrane domain of the protein was identified in index patients and their unaffected mothers. Functional studies revealed that variant receptors show decreased current response evoked by agonist (ie, kainic acid and glutamate) and reduced expression on the cell surface in favor of pathogenicity by a loss-of-function mechanism. CONCLUSIONS: Taken together, our results suggest that apart from known GRIA3-related disorders, an undescribed mutation-specific singular movement disorder does exist. We thus advocate considering GRIA3 mutations in the differential diagnosis of hyperekplexia and generalized chorea with myoclonus. © 2020 International Parkinson and Movement Disorder Society.

???displayArticle.pubmedLink??? 32369665
???displayArticle.pmcLink??? PMC9190290
???displayArticle.link??? Mov Disord
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis

???displayArticle.disOnts??? hyperekplexia [+]
References [+] :

Allen, De novo mutations in epileptic encephalopathies. 2013, Pubmed

Allen, De novo mutations in epileptic encephalopathies. 2013, Pubmed
Amin, A conserved glycine harboring disease-associated mutations permits NMDA receptor slow deactivation and high Ca2+ permeability. 2018, Pubmed
Bohlega, Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders. 2019, Pubmed
Bonnet, Aberrant GRIA3 transcripts with multi-exon duplications in a family with X-linked mental retardation. 2009, Pubmed
Bonnet, Exploring the potential role of disease-causing mutation in a gene desert: duplication of noncoding elements 5' of GRIA3 is associated with GRIA3 silencing and X-linked intellectual disability. 2012, Pubmed
Broix, Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia. 2016, Pubmed
Chen, Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy. 2017, Pubmed
Chiyonobu, Partial tandem duplication of GRIA3 in a male with mental retardation. 2007, Pubmed
Davies, A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disability. 2017, Pubmed
Flicek, Ensembl 2012. 2012, Pubmed
Gécz, Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. 1999, Pubmed
Hackmann, Partial deletion of GLRB and GRIA2 in a patient with intellectual disability. 2013, Pubmed
Hollmann, Cloning by functional expression of a member of the glutamate receptor family. 1989, Pubmed , Xenbase
Jin, A novel 47.2 Mb duplication on chromosomal bands Xq21.1-25 associated with mental retardation. 2015, Pubmed
Keinänen, A family of AMPA-selective glutamate receptors. 1990, Pubmed
Lam, A novel assay for measurement of membrane-protein surface expression using a β-lactamase. 2013, Pubmed
Li, GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. 2016, Pubmed
Lyu, [Analysis of a patient with X-linked mental retardation by next generation sequencing]. 2018, Pubmed
Martin, De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities. 2017, Pubmed
Masri, Hyperekplexia: Report on phenotype and genotype of 16 Jordanian patients. 2017, Pubmed
Ogden, Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology. 2017, Pubmed , Xenbase
Parnes, Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations. 2019, Pubmed
Philippe, Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance. 2013, Pubmed
Philips, X-exome sequencing in Finnish families with intellectual disability--four novel mutations and two novel syndromic phenotypes. 2014, Pubmed
Poot, Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders. 2013, Pubmed
Sobolevsky, X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. 2009, Pubmed
Strehlow, GRIN2A-related disorders: genotype and functional consequence predict phenotype. 2019, Pubmed
Swanger, Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains. 2016, Pubmed
Traynelis, Glutamate receptor ion channels: structure, regulation, and function. 2010, Pubmed
van der Veen, Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force. 2019, Pubmed
Wu, Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. 2007, Pubmed
XiangWei, Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy. 2019, Pubmed